LJPC
La Jolla Pharmaceutical Company
LJPC
LJPC
Delisted
LJPC was delisted on the 19th of August, 2022.
73 hedge funds and large institutions have $79.4M invested in La Jolla Pharmaceutical Company in 2020 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 24 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
13% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 24
18% less call options, than puts
Call options by funds: $464K | Put options by funds: $563K
Holders
73
Holding in Top 10
2
Calls
$464K
Puts
$563K
Top Buyers
| 1 | +$13.2M | |
| 2 | +$1.08M | |
| 3 | +$547K | |
| 4 |
BC
Boxer Capital
San Diego,
California
|
+$486K |
| 5 |
Two Sigma Investments
New York
|
+$306K |
Top Sellers
| 1 | -$2.53M | |
| 2 | -$1.12M | |
| 3 | -$770K | |
| 4 |
Goldman Sachs
New York
|
-$762K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$512K |